NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)

Estimated Value: $1,000,000
Open 186 days left Healthcaregrant
Dec 5, 2024
Jan 7, 2027 12:00 AM
Healthcare
grant
AI Summary
This is a funding opportunity (PAR-25-025) from the NHLBI for early phase clinical trials related to therapeutics and/or diagnostics for Heart, Lung, Blood, and Sleep (HLBS) disorders. It requires an R33 CT (Clinical Trial) application.
Line Items
ItemQtyUnitEst. Unit PriceEst. TotalCategory
Early Phase Clinical Trial for Therapeutics for HLBS Disorders 1 each $500,000.00 $500,000.00 Medical
Early Phase Clinical Trial for Diagnostics for HLBS Disorders 1 each $500,000.00 $500,000.00 Medical
Estimated Bid Value$1,000,000.00

Want the full details?

Sign up free to see the agency name, contact info, and the original bid posting link.

Sign Up Free →

Related Bids

Browse More Bids

Healthcare BidsGRANT BidsClosing Soon All Bids